More interestingly, as chemotherapy always induce the up-regulation of PD-L1 and induce immune escape [38–41], we found that PSB-based therapy did not induce the increased expression of PD-L1, which would enhance tumor immunotherapy (Fig. 1). The gene discussed is CD274; the disease is neoplasm.